TOM WILLIAMS/POOL/AFP via Getty Images

ByElaine ChenandChelsea Cirruzzo

Sept. 16, 2026

Elaine Chen

[email protected]

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writesThe Readout newsletter, and co-hosts STAT’s weekly biotech podcast,The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Chelsea Cirruzzo

[email protected]

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42.

Want to stay on top of the science and politics driving biotech today?Sign upto get our biotech newsletter in your inbox.

Good morning. We’ve got a D.C.-heavy newsletter for you today.

Advertisement

FDA starts program to get drugs in the clinic faster

The FDA is opening applications for a pilot program designed to speed up the timeline for drugmakers to enter the clinic.

STAT+ Exclusive Story

Already have an account?Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account?Log in

Monthly

$39

Totals $468 per year

$39/monthGet Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 monthsGet Started

Then $399/year

Annual

$399

Save 15%

$399/yearGet Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A QuoteRequest A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/yearGet Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

SubscribeLog Inbiotechnology

,

drug development

,

Drug prices

,

researchSubmit a correction requestReprints

  1. Elaine Chen

    National Biotech Reporter

    Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writesThe Readout newsletter, and co-hosts STAT’s weekly biotech podcast,The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

  2. Chelsea Cirruzzo

    Washington Correspondent

    Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42.

Newsletter

Understand how science, health policy, and medicine shape the world every day